Browsing by Author "Mahen, Kala"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Alcohol-induced gut microbial reorganization and associated overproduction of phenylacetylglutamine promotes cardiovascular disease
    (Springer Nature, 2024-12-30) Li, Zhen; Gu, Min; Zaparte, Aline; Fu, Xiaoming; Mahen, Kala; Mrdjen, Marko; Li, Xinmin S.; Yang, Zhihong; Ma, Jing; Thoudam, Themis; Chandler, Kristina; Hesler, Maggie; Heathers, Laura; Gorse, Kiersten; Van, Thanh Trung; Wong, David; Gibson, Aaron M.; Wang, Zeneng; Taylor, Christopher M.; Quijada, Pearl; Makarewich, Catherine A.; Hazen, Stanley L.; Liangpunsakul, Suthat; Brown, J. Mark; Lefer, David J.; Welsh, David A.; Sharp, Thomas E., III; Medicine, School of Medicine
    The mechanism(s) underlying gut microbial metabolite (GMM) contribution towards alcohol-mediated cardiovascular disease (CVD) is unknown. Herein we observe elevation in circulating phenylacetylglutamine (PAGln), a known CVD-associated GMM, in individuals living with alcohol use disorder. In a male murine binge-on-chronic alcohol model, we confirm gut microbial reorganization, elevation in PAGln levels, and the presence of cardiovascular pathophysiology. Fecal microbiota transplantation from pair-/alcohol-fed mice into naïve male mice demonstrates the transmissibility of PAGln production and the CVD phenotype. Independent of alcohol exposure, pharmacological-mediated increases in PAGln elicits direct cardiac and vascular dysfunction. PAGln induced hypercontractility and altered calcium cycling in isolated cardiomyocytes providing evidence of improper relaxation which corresponds to elevated filling pressures observed in vivo. Furthermore, PAGln directly induces vascular endothelial cell activation through induction of oxidative stress leading to endothelial cell dysfunction. We thus reveal that the alcohol-induced microbial reorganization and resultant GMM elevation, specifically PAGln, directly contributes to CVD.